Canopy Growth - CEO, David Klein.
CEO, David Klein.
Source: Nasdaq and Vanja Savic.
  • Canopy Growth (TSX:WEED) is announcing a private placement with institutional investors for up to US$50 million
  • Management intends to use the funds for working capital and general corporate purposes
  • Canopy Growth is a North American cannabis and consumer packaged goods company
  • Canopy Growth stock (TSX:WEED) is up by 258.82 per cent since its 52-week low on July 14, 2023

Canopy Growth (TSX:WEED) is announcing a private placement with institutional investors for up to US$50 million.

Management intends to use the funds to strengthen its balance sheet through working capital and general corporate purposes.

The agreement entails the sale of up to 22,929,468 units priced at US$1.09 for proceeds of US$25 million.

Each unit is composed of one WEED common share and one common share purchase warrant. Each warrant entitles the holder to acquire one common share for US$1.35 for up to five years from issuance.

The institutional investors hold an over-allotment option to acquire up to an additional 22,929,468 units at the US$1.09 price.

Closing of the agreement (not including the over-allotment option) is expected by Tuesday.

The news follows a stretch of positive momentum for Canopy Growth’s stock, as highlighted by:

Canopy Growth is a North American cannabis and consumer packaged goods company. Its brands include Doja, 7ACRES, Tweed, Deep Space, This Works, Martha Stewart CBD and Storz & Bickel.

The company is positioned to capitalize on U.S. cannabis legalization through its rights to Acreage Holdings, a vertically integrated multi-state cannabis operator across the Northeast; Wana Brands, a leading cannabis edible brand in North America; and Jetty Extracts, a California-based producer of cannabis extracts and pioneer of clean vape technology.

Canopy Growth stock (TSX:WEED) last traded at $1.83 per share. The stock is up by 258.82 per cent since its 52-week low on July 14, 2023.

Join the discussion: Find out what everybody’s saying about this Canadian cannabis stock on the Canopy Growth Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

Puff, puff, profit: Aurora Cannabis earns record revenue and adjusted EBITDA

Aurora Cannabis (TSX:ACB) earned record annual revenue and adjusted EBITDA in fiscal 2026, substantiating its shift into the medical market.

The 5-Minute Investor Podcast, Ep. 65: Cannabis stocks cultivating alpha

Listen to episode 65 of The 5-Minute Investor Podcast, featuring analysis on cannabis stocks Decibel Cannabis and Aurora Cannabis.
Stock Talk Cannabis Report image of cannabis plants and VW van

StockTalk | Cannabis Report: Results, awards, & upgrades

Aurora Cannabis Inc. (TSX/NASDAQ:ACB), a Canadian-based global medical cannabis company, reported its financial and operational results...

Decibel Cannabis cranks up the volume with strong Q1 growth

Decibel Cannabis Company (TSXV:DB) reported that revenue rose 41 per cent year over year to about C$30 million.